Milken Institute’s Future of Health

Tempus Founder and CEO, Eric Lefkofsky, joins the panel "Building the Clinical Trial Enterprise of the Future"

Dec 13, 2022

Media Coverage

Related content

Tempus Expands Strategic Collaboration with Bristol Myers Squibb

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Tempus to Report Third Quarter 2026 Financial Results on November 2